Analysis of tumors from a second pair of independent cohorts of patients, who had received adjuvant antiestrogen monotherapy, identified loss of Nuc-Stat5a protein as an independent marker associated with greater than fourfold increased risk of death from breast cancer in this population. The gene discussed is STAT5A; the disease is breast cancer.